Banco Bilbao Vizcaya Argentaria’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.37M	Sell	13,762 -207	-1%	-$38.4K	0.02%	408
2025 Q4	$2.79M	Sell	13,969 -590	-4%	-$107K	0.02%	381
2025 Q3	$2.28M	Buy	14,559 +403	+3%	+$64K	0.02%	404
2025 Q2	$2.15M	Buy	14,156 +11,047	+355%	+$1.47M	0.02%	395
2025 Q1	$465K	Buy	3,109 +879	+39%	+$147K	﹤0.01%	611
2024 Q4	$411K	Sell	2,230 -657	-23%	-$127K	﹤0.01%	615
2024 Q3	$569K	Sell	2,887 -410	-12%	-$85.2K	0.01%	606
2024 Q2	$683K	Sell	3,297 -734	-18%	-$166K	0.01%	584
2024 Q1	$1.09M	Buy	4,031 +1,449	+56%	+$346K	0.01%	533
2023 Q4	$609K	Buy	2,582 +219	+9%	+$43.1K	0.01%	613
2023 Q3	$463K	Buy	2,363 +921	+64%	+$189K	0.01%	633
2023 Q2	$303K	Sell	1,442 -109	-7%	-$21.7K	﹤0.01%	670
2023 Q1	$313K	Buy	1,551 +281	+22%	+$63.7K	﹤0.01%	671
2022 Q4	$277K	Buy	1,270 +57	+5%	+$12.4K	﹤0.01%	666
2022 Q3	$239K	Sell	1,213 -17	-1%	-$3.67K	﹤0.01%	683
2022 Q2	$263K	Buy	1,230 +122	+11%	+$29.8K	﹤0.01%	650
2022 Q1	$321K	Sell	1,108 -155	-12%	-$47.8K	﹤0.01%	657
2021 Q4	$475K	Buy	1,263 +28	+2%	+$10.9K	0.01%	677
2021 Q3	$510K	Buy	1,235 +25	+2%	+$10.4K	0.01%	612
2021 Q2	$448K	Buy	+1,210	New	+$404K	0.01%	639